Bausch & Lomb BLCO
NYSE BLCO
$17.56 -0.23 (-1.29%)
As of: Sep 10, 2026 · 3:59 PM EDT

Bausch & Lomb (BLCO) Liabilities and Shareholders Equity (2021 - 2026)

Bausch & Lomb's (BLCO) quarterly Liabilities and Shareholders Equity came in at $13.9 billion in Q2 2026, little changed on a YoY basis from $13.8 billion in Q2 2025, and up 0.57% quarter-over-quarter from $13.8 billion in Q1 2026.

Analysis

Bausch & Lomb (BLCO) Liabilities and Shareholders Equity (2021 - 2026) Analysis & Trends

Bausch & Lomb (BLCO) has reported Liabilities and Shareholders Equity for 6 consecutive years, with $13.9 billion the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Liabilities and Shareholders Equity changed 0.2% year-over-year to $13.9 billion; the trailing twelve-month figure through Jun 2026 stood at $55.5 billion (up 2.3% YoY), and the FY2025 full-year result was $14.0 billion, up 4.11% from the prior year.
  • Liabilities and Shareholders Equity grew to $13.9 billion in Q2 2026 per BLCO's latest filing, from $13.8 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $14.0 billion in Q4 2025 and bottomed at $10.7 billion in Q3 2022.
  • Historically, Liabilities and Shareholders Equity has averaged $12.7 billion across 5 years, with a median of $13.4 billion in 2024.
  • The sharpest annual moves came in 2023 and 2026: Liabilities and Shareholders Equity gained 22.18% in 2023, then advanced 0.2% in 2026.
  • Over 5 years, Liabilities and Shareholders Equity stood at $11.1 billion in 2022, then grew by 20.62% to $13.4 billion in 2023, then climbed by 0.2% to $13.5 billion in 2024, then gained by 4.11% to $14.0 billion in 2025, then decreased by 1.16% to $13.9 billion in 2026.
  • According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $13.9 billion, $13.8 billion, and $14.0 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn 109.22 Bn
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn 20.88 Bn
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn 93.31 Bn
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn 47.93 Bn
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn 45.22 Bn
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn 13.87 Bn
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn 31.10 Bn
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn 6.46 Bn
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn 10.74 Bn
10 Bausch & Lomb 6.28 Bn 5.90 Bn 867.00 Mn 13.86 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 13.86 Bn
Mar 31, 2026 13.78 Bn
Dec 31, 2025 14.02 Bn
Sep 30, 2025 13.83 Bn
Jun 30, 2025 13.83 Bn
Mar 31, 2025 13.43 Bn
Dec 31, 2024 13.47 Bn
Sep 30, 2024 13.52 Bn
Jun 30, 2024 13.25 Bn
Mar 31, 2024 13.29 Bn
Dec 31, 2023 13.44 Bn
Sep 30, 2023 13.07 Bn
Jun 30, 2023 11.32 Bn
Mar 31, 2023 11.17 Bn
Dec 31, 2022 11.14 Bn
Sep 30, 2022 10.70 Bn
Jun 30, 2022 11.00 Bn
Mar 31, 2022 10.91 Bn
Dec 31, 2021 10.82 Bn